Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 596.76 Million CNY | -19.49% |
| 2022 | 651.18 Million CNY | -0.31% |
| 2021 | 653.19 Million CNY | -24.1% |
| 2020 | 860.62 Million CNY | 123.99% |
| 2019 | 384.21 Million CNY | 9.99% |
| 2018 | 349.32 Million CNY | 142.91% |
| 2017 | 143.8 Million CNY | 42.68% |
| 2016 | 100.78 Million CNY | -0.22% |
| 2015 | 101.01 Million CNY | -27.58% |
| 2014 | 139.47 Million CNY | 10.76% |
| 2013 | 125.92 Million CNY | 18.19% |
| 2012 | 106.54 Million CNY | -4.31% |
| 2011 | 111.34 Million CNY | -5.25% |
| 2010 | 117.51 Million CNY | 12.78% |
| 2009 | 104.19 Million CNY | 36.16% |
| 2008 | 76.52 Million CNY | 60.47% |
| 2007 | 47.68 Million CNY | 2.94% |
| 2006 | 46.32 Million CNY | 56.29% |
| 2005 | 29.64 Million CNY | 89.91% |
| 2004 | 15.6 Million CNY | 45.95% |
| 2003 | 10.69 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 158.77 Million CNY | 11.47% |
| 2024 Q2 | 124.65 Million CNY | 16.37% |
| 2024 Q1 | 107.12 Million CNY | 10.77% |
| 2023 Q1 | 131.78 Million CNY | -40.68% |
| 2023 Q2 | 121.11 Million CNY | -8.1% |
| 2023 Q3 | 174.66 Million CNY | 44.21% |
| 2023 Q4 | 96.7 Million CNY | -44.63% |
| 2023 FY | 524.27 Million CNY | -19.49% |
| 2022 Q2 | 102.18 Million CNY | -24.1% |
| 2022 FY | 651.18 Million CNY | -0.31% |
| 2022 Q3 | 192.22 Million CNY | 88.12% |
| 2022 Q4 | 222.15 Million CNY | 15.57% |
| 2022 Q1 | 134.62 Million CNY | -35.02% |
| 2021 FY | 653.19 Million CNY | -24.1% |
| 2021 Q1 | 150.14 Million CNY | -32.86% |
| 2021 Q2 | 169.98 Million CNY | 13.21% |
| 2021 Q3 | 125.89 Million CNY | -25.94% |
| 2021 Q4 | 207.16 Million CNY | 64.56% |
| 2020 Q3 | 260.43 Million CNY | 13.5% |
| 2020 Q4 | 223.64 Million CNY | -14.13% |
| 2020 Q1 | 147.08 Million CNY | 40.21% |
| 2020 Q2 | 229.45 Million CNY | 56.0% |
| 2020 FY | 860.62 Million CNY | 123.99% |
| 2019 Q4 | 104.9 Million CNY | 11.05% |
| 2019 Q1 | 89.87 Million CNY | -23.47% |
| 2019 Q2 | 94.96 Million CNY | 5.66% |
| 2019 Q3 | 94.46 Million CNY | -0.52% |
| 2019 FY | 384.21 Million CNY | 9.99% |
| 2018 Q3 | 92.5 Million CNY | 12.11% |
| 2018 Q4 | 117.44 Million CNY | 26.96% |
| 2018 FY | 349.32 Million CNY | 142.91% |
| 2018 Q1 | 56.86 Million CNY | -9.89% |
| 2018 Q2 | 82.51 Million CNY | 45.11% |
| 2017 Q3 | 34.28 Million CNY | 39.53% |
| 2017 Q2 | 24.56 Million CNY | 12.42% |
| 2017 Q1 | 21.85 Million CNY | -17.95% |
| 2017 FY | 143.8 Million CNY | 42.68% |
| 2017 Q4 | 63.1 Million CNY | 84.09% |
| 2016 Q1 | 23.46 Million CNY | -12.53% |
| 2016 FY | 100.78 Million CNY | -0.22% |
| 2016 Q4 | 26.63 Million CNY | 8.13% |
| 2016 Q3 | 24.63 Million CNY | -5.46% |
| 2016 Q2 | 26.05 Million CNY | 11.02% |
| 2015 Q4 | 26.83 Million CNY | -1.34% |
| 2015 Q1 | 19.26 Million CNY | -50.45% |
| 2015 FY | 101.01 Million CNY | -27.58% |
| 2015 Q2 | 27.72 Million CNY | 43.97% |
| 2015 Q3 | 27.19 Million CNY | -1.92% |
| 2014 FY | 139.47 Million CNY | 10.76% |
| 2014 Q3 | 39.97 Million CNY | 5.03% |
| 2014 Q1 | 22.57 Million CNY | -51.12% |
| 2014 Q4 | 38.86 Million CNY | -2.76% |
| 2014 Q2 | 38.05 Million CNY | 68.55% |
| 2013 Q3 | 31.48 Million CNY | 17.2% |
| 2013 Q1 | 21.38 Million CNY | -44.07% |
| 2013 Q2 | 26.86 Million CNY | 25.61% |
| 2013 Q4 | 46.19 Million CNY | 46.74% |
| 2013 FY | 125.92 Million CNY | 18.19% |
| 2012 FY | 106.54 Million CNY | -4.31% |
| 2012 Q3 | 25.01 Million CNY | 3.08% |
| 2012 Q2 | 24.26 Million CNY | 27.52% |
| 2012 Q1 | 19.02 Million CNY | -53.04% |
| 2012 Q4 | 38.23 Million CNY | 52.86% |
| 2011 Q1 | 24.62 Million CNY | -45.18% |
| 2011 FY | 111.34 Million CNY | -5.25% |
| 2011 Q2 | 21.6 Million CNY | -12.27% |
| 2011 Q4 | 40.52 Million CNY | 64.77% |
| 2011 Q3 | 24.59 Million CNY | 13.81% |
| 2010 Q2 | 26.04 Million CNY | 20.55% |
| 2010 Q4 | 44.92 Million CNY | 80.07% |
| 2010 Q1 | 21.6 Million CNY | -41.28% |
| 2010 Q3 | 24.94 Million CNY | -4.19% |
| 2010 FY | 117.51 Million CNY | 12.78% |
| 2009 FY | 104.19 Million CNY | 36.16% |
| 2009 Q4 | 36.79 Million CNY | 40.23% |
| 2009 Q3 | 26.23 Million CNY | 12.46% |
| 2009 Q2 | 23.33 Million CNY | 30.8% |
| 2009 Q1 | 17.83 Million CNY | -21.93% |
| 2008 FY | 76.52 Million CNY | 60.47% |
| 2008 Q3 | 19.12 Million CNY | 2.11% |
| 2008 Q1 | 15.81 Million CNY | 50.41% |
| 2008 Q2 | 18.73 Million CNY | 18.48% |
| 2008 Q4 | 22.84 Million CNY | 19.44% |
| 2007 Q2 | 14.42 Million CNY | 46.01% |
| 2007 Q4 | 10.51 Million CNY | -18.32% |
| 2007 Q1 | 9.87 Million CNY | -45.05% |
| 2007 FY | 47.68 Million CNY | 2.94% |
| 2007 Q3 | 12.87 Million CNY | -10.77% |
| 2006 Q4 | 17.97 Million CNY | 58.86% |
| 2006 Q3 | 11.31 Million CNY | 17.68% |
| 2006 Q2 | 9.61 Million CNY | 29.68% |
| 2006 Q1 | 7.41 Million CNY | -21.67% |
| 2006 FY | 46.32 Million CNY | 56.29% |
| 2005 Q3 | 10.72 Million CNY | 0.0% |
| 2005 Q4 | 9.46 Million CNY | -11.71% |
| 2005 FY | 29.64 Million CNY | 89.91% |
| 2004 FY | 15.6 Million CNY | 45.95% |
| 2003 FY | 10.69 Million CNY | 0.0% |